Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles

被引:16
作者
Beer, Ambros J. [2 ]
Holzapfel, Konstantin [1 ]
Neudorfer, Juliana [3 ]
Piontek, Guido [4 ]
Settles, Marcus [1 ]
Kroenig, Holger [3 ]
Peschel, Christian [3 ]
Schlegel, Juergen [4 ]
Rummeny, Ernst J. [1 ]
Bernhard, Helga [3 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Hematol Oncol, D-81675 Munich, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol, Div Neuropathol, D-81675 Munich, Germany
关键词
MR imaging; molecular imaging; iron oxides; cytotoxic T lymphocytes;
D O I
10.1007/s00330-008-0874-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
New technologies are needed to characterize the migration and survival of antigen-specific T cells in vivo. In this study, we developed a novel technique for the labeling of human cytotoxic T lymphocytes with superparamagnetic iron-oxide particles and the subsequent depiction with a conventional 1.5-T magnetic resonance scanner. Antigen-specific CD8(+) T lymphocytes were labeled with ferucarbotran by lipofection. The uptake of ferucarbotran was confirmed by immunofluorescence microscopy using a dextran-specific antibody, and the intracellular enrichment of iron was measured by atomic absorption spectrometry. The imaging of T cells was performed by magnetic resonance on day 0, 2, 7 and 14 after the labeling procedure. On day 0 and 2 post labeling, a pronounced shortening of T2*-relaxation times was observed, which diminished after 7 days and was not detectable anymore after 14 days, probably due to the retained mitotic activity of the labeled T cells. Of importance, the antigen-specific cytolytic activity of the T cells was preserved following ferucarbotran labeling. Efficient ferucarbotran labeling of functionally active T lymphocytes and their detection by magnetic resonance imaging allows the in vivo monitoring of T cells and, subsequently, will impact the further development of T cell-based therapies.
引用
收藏
页码:1087 / 1095
页数:9
相关论文
共 44 条
[1]   Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography [J].
Adonai, N ;
Nguyen, KN ;
Walsh, J ;
Iyer, M ;
Toyokuni, T ;
Phelps, ME ;
McCarthy, T ;
McCarthy, DW ;
Gambhir, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3030-3035
[2]   Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging [J].
Anderson, SA ;
Lee, KK ;
Frank, JA .
INVESTIGATIVE RADIOLOGY, 2006, 41 (03) :332-338
[3]  
Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697
[4]   Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells [J].
Arbab, AS ;
Yocum, GT ;
Rad, AM ;
Khakoo, AY ;
Fellowes, V ;
Read, EJ ;
Frank, JA .
NMR IN BIOMEDICINE, 2005, 18 (08) :553-559
[5]   Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic reisonance imaging after cell transplantation: Methods and techniques [J].
Arbab, AS ;
Bashaw, LA ;
Miller, BR ;
Jordan, EK ;
Bulte, JWM ;
Frank, JA .
TRANSPLANTATION, 2003, 76 (07) :1123-1130
[6]   Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].
Barbash, IM ;
Chouraqui, P ;
Baron, J ;
Feinberg, MS ;
Etzion, S ;
Tessone, A ;
Miller, L ;
Guetta, E ;
Zipori, D ;
Kedes, LH ;
Kloner, RA ;
Leor, J .
CIRCULATION, 2003, 108 (07) :863-868
[7]   Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells [J].
Barnett, Brad P. ;
Arepally, Aravind ;
Karmarkar, Parag V. ;
Qian, Di ;
Gilson, Wesley D. ;
Walczak, Piotr ;
Howland, Valerie ;
Lawler, Leo ;
Lauzon, Cal ;
Stuber, Matthias ;
Kraitchman, Dara L. ;
Bulte, Jeff W. M. .
NATURE MEDICINE, 2007, 13 (08) :986-991
[8]   Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer [J].
Bernhard, Helga ;
Neudorfer, Julia ;
Gebhard, Kerstin ;
Conrad, Heinke ;
Hermann, Christine ;
Naehrig, Joerg ;
Fend, Falko ;
Weber, Wolfgang ;
Busch, Dirk H. ;
Peschel, Christian .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (02) :271-280
[9]   T-Cell homing to the pancreas in autoimmune mouse model of diabetes: In vivo MR imaging [J].
Billotey, C ;
Aspord, C ;
Beuf, O ;
Piaggio, E ;
Gazeau, F ;
Janier, MF ;
Thivolet, C .
RADIOLOGY, 2005, 236 (02) :579-587
[10]   Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease [J].
Bollard, CM ;
Aguilar, L ;
Straathof, KC ;
Gahn, B ;
Huls, MH ;
Rousseau, A ;
Sixbey, J ;
Gresik, MV ;
Carrum, G ;
Hudson, M ;
Dilloo, D ;
Gee, A ;
Brenner, MK ;
Rooney, CM ;
Heslop, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (12) :1623-1633